Company Information
Name:
Allergan Middle East Ltd.
Trading Name:
Allergan Middle East
Status of Registration:
Active
Type of License:
Non Regulated
Legal Structure:
Private Company
Date of Incorporation :
27 Feb 2017
Commercial License Validity Date:
26 Feb 2021
Directors:
Djamshid Ghavami
Eliane Mouawad
Reginald Mudangwe
Oleg Zujev
Shareholders:
Allergan Holdings Limited
Company Secretary:
Faizal Latheef
DNFBP: 
Designated Non-Financial Businesses and Professions
No
Financial Year End:
31st December
Class of Issued Shares:
A
Nominal Value of One Share:
USD 500.000000
Number of Issued Shares:
100.000000
Data Protection
Data Protection Officer Appointed:
No
Notifications:
Personal Data Processing Operations:
No
Transfer of Personal Data from the DIFC:
No
Processing of Special Categories of Personal Data:
No
Former Properties
Company Secretary:
Adel Khalaf until 05 July 2020
Directors:
Ahmed Samy until 05 November 2018
Umberto La Magna until 19 November 2017
Gavin Scott Morant Smith until 16 May 2017
Maha Mostafa Ahmed Shafik until 18 June 2017
Jason Smith until 28 February 2018
Ramsey Morad until 27 May 2020
Rasha El Hibri until 20 December 2020
